Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows From Operating Activities    
Net loss $ (1,164,630) $ (101,134,331)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 290,181 323,186
Accretion of interest expense 239,711
Amortization of discount on convertible debt 528,929 1,863,680
Change in fair value of derivative and other accrued liabilities (4,997,721) 72,882,216
Loss on inducement 7,570,581
Provision for bad debt 80,845 38,275
Loss on settlement reserve 127,941
Loss on settlement of liabilities for equity 2,136,860
Gain on settlement of liabilities to JMJ for equity (5,800,175)
Interest expense - related party share transfer (see Note 9) 785,200
Gain on settlement of accounts payable, net (920,352) (22,914)
Loss on deconsolidation of 350 Green 97,152
Loss on disposal of property and equipment 12,698
Non-compliance penalty for SEC registration requirement 73,498
Common stock 3,512,558 670,003
Options 58,664 155,938
Warrants 114,069 606,891
Changes in operating assets and liabilities:    
Accounts receivable and other receivables (60,049) (69,354)
Inventory (482,496) 160,829
Prepaid expenses and other current assets (824,925) (27,781)
Other assets 2,636 49,536
Accounts payable and accrued expenses (3,970,155) 14,743,743
Deferred revenue (14,140) (240,880)
Total Adjustments (9,419,432) 99,114,310
Net Cash Used in Operating Activities (10,584,062) (2,020,021)
Cash Flows From Investing Activities    
Purchases of property and equipment (37,711) (12,681)
Net Cash Used In Investing Activities (37,711) (12,681)
Cash Flows From Financing Activities    
Proceeds from sale of common stock in public offering [1] [1] 16,243,055
Payment of public offering costs (1,190,082)
Payments of deferred offering costs (38,263)
Payments of debt issuance costs (72,945)
Bank overdrafts, net 84,144
Proceeds from issuance of convertible note payable 1,550,100
Proceeds from exercise of warrants 17,143,056
Proceeds from issuance of notes payable to non-related party 55,000 260,000
Proceeds from advance from a related party 250,000 257,645
Repayment of notes and convertible notes payable (760,000) (4,815)
Net Cash Provided by Financing Activities 31,741,029 2,035,866
Net Increase In Cash 21,119,256 3,164
Cash - Beginning of Period 185,151 5,898
Cash - End of Period 21,304,407 9,062
Supplemental Disclosures of Cash Flow Information:    
Interest expense 36,132 44
Non-cash investing and financing activities:    
Common stock issued in partial satisfaction of debt and other liabilities 4,353,988
Reduction of additional paid-in capital for public offering issuance costs that were previously paid (172,158)
Common stock issued upon conversion of Series A convertible preferred stock 11,000
Common stock issued in satisfaction of Series B convertible preferred stock 825,000
Common stock issued upon conversion of Series C convertible preferred stock 255
Common stock issued upon conversion of Series D convertible preferred stock 7
Issuance of common stock for services previously accrued 181,924
Warrants issued in satisfaction of accrued issuable equity 409,042
Return and retirement of common stock 2,942
Warrants reclassified from derivative liabilities 36,445
Accrual of contractual dividends on Series C Convertible Preferred Stock 607,800 2,374,300
Issuance of Series C Convertible Preferred Stock in satisfaction of contractual dividends 2,500,600 2,731,500
Issuance of Series C Convertible Preferred Stock in satisfaction of public information fee 3,023,500
Issuance of Series C Convertible Preferred Stock in satisfaction registration rights penalty 1,245,500
Accrual of warrant obligation in connection with issuance of notes payable 8,616
Transfer of inventory to property and equipment (35,908) (19,029)
Accrual of deferred public offering costs 407,679
Issuance or accrual of common stock, warrants and embedded conversion options as debt discount in connection with the issuance of notes payable 1,382,224
Series D convertible preferred stock issued in satisfaction of liabilities 12,005,000
Issuance of common stock in exchange for warrants 46,387,833
Return and retirement of common stock previously held as collateral $ 67,058
[1] Includes gross proceeds of $18,504,320, less issuance costs of $2,261,265 deducted directly from the offering proceeds.